LEADER 06080nam 2200781Ia 450 001 9910458841103321 005 20200520144314.0 010 $a1-281-01913-5 010 $a9786611019136 010 $a0-08-054977-2 035 $a(CKB)1000000000383609 035 $a(EBL)307154 035 $a(OCoLC)173609891 035 $a(SSID)ssj0000141668 035 $a(PQKBManifestationID)11147204 035 $a(PQKBTitleCode)TC0000141668 035 $a(PQKBWorkID)10057101 035 $a(PQKB)10104923 035 $a(SSID)ssj0001405295 035 $a(PQKBManifestationID)12625050 035 $a(PQKBTitleCode)TC0001405295 035 $a(PQKBWorkID)11387202 035 $a(PQKB)11632783 035 $a(MiAaPQ)EBC307154 035 $a(Au-PeEL)EBL307154 035 $a(CaPaEBR)ebr10186707 035 $a(EXLCZ)991000000000383609 100 $a20020118d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aDrugs during pregnancy and lactation$b[electronic resource] $ehandbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs, diagnostic procedures, vaccinations, poisoning, workplace and environmental contaminants, and breastfeeding during infectious disease /$fedited by Christof Schaefer 205 $a2nd ed. 210 $aAmsterdam ;$aNew York $cElsevier$d2007 215 $a1 online resource (907 p.) 300 $aDescription based upon print version of record. 311 $a0-444-50763-9 311 $a0-444-52072-4 320 $aIncludes bibliographic references and index. 327 $aFront cover; Drugs During Pregnancy and Lactation, Second edition; Copyright page; Contents; List of contributors; Preface; Notice; Chapter 1 General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics in pregnancy; 1.8 Passage of drugs to the unborn and fetal kinetics; 1.9 Causes of developmental disorders 327 $a1.10 Embryo/fetotoxic risk assessment1.11 Classification of drugs used in pregnancy; 1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety (or otherwise) of drugs already used in pregnancy; 1.16 Teratology information centers; Chapter 2 Specific drug therapies during pregnancy; 2.1 Analgesics and anti-inflammatory drugs; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Aspirin (acetylsalicylic acid); 2.1.3 Pyrazolone derivatives 327 $a2.1.4 Combination analgesic preparations2.1.5 Opioid analgesics in general; 2.1.6 Morphine; 2.1.7 Codeine; 2.1.8 Pethidine (meperidine); 2.1.9 Fentanyl, alfentanil, remifentanil, and sufentanil; 2.1.10 Other narco-analgesics and centrally acting analgesics; 2.1.11 Naloxone; 2.1.12 Nonsteroidal anti-inflammatory drugs (NSAIDs); 2.1.13 Selective cyclooxygenase-2 (COX-2) inhibitors; 2.1.14 Migraine medications; 2.1.15 Additional analgesics; 2.1.16 Additional antiphlogistics and antirheumatics; 2.1.17 Myotonolytics; 2.1.18 Gout interval therapy; 2.1.19 Gout attack therapy 327 $a2.2 Antiallergic drugs and desensitization2.2.1 Antihistamines (H[sub(1)]-blocker); 2.2.2 Glucocorticosteroids; 2.2.3 Mast cell stabilizers; 2.2.4 Immunotherapy; 2.3 Antiasthmatic and cough medication; 2.3.1 Asthma and pregnancy; 2.3.2 Selective ?[sub(2)]-adrenergic agonists; 2.3.3 Corticosteroids; 2.3.4 Anticholinergic drugs; 2.3.5 Theophylline; 2.3.6 Cromoglycate, nedocromil, and lodoxamide; 2.3.7 Other mast cell inhibitors; 2.3.8 Antileukotrienes; 2.3.9 Monoclonal antibodies and other asthma medications; 2.3.10 Expectorants and mucolytic agents; 2.3.11 Antitussives 327 $a2.3.12 Non-selective ?-adrenergic agonists2.4 Antiemetics; 2.4.1 Nausea and vomiting in pregnancy; 2.4.2 Diet manipulations and treatment; 2.4.3 Complementary treatment options; 2.4.4 Acupuncture and acupressure; 2.4.5 Hypnosis; 2.4.6 Ginger; 2.4.7 Antihistamines (H[sub(1)]-blockers); 2.4.8 Dopamine antagonists; 2.4.9 Pyridoxine (vitamin B[sub(6)]); 2.4.10 Thiamine (vitamin B[sub(1)]); 2.4.11 Serotonin antagonists; 2.4.12 Glucocorticoids; 2.4.13 Other agents with antiemetic properties; 2.5 Gastrointestinal and antilipidemic agents and spasmolytics 327 $a2.5.1 Gastritis and peptic ulcer during pregnancy 330 $aThe latest edition is the resource for any practicing OB/GYN, family physician, midwife, or pharmacist who prescribes medicinal products to or evaluates environmental or occupational exposures in women who are or may become pregnant. Based on the highly successful seven German editions of this reference, the up-to-date drug listings have been revised into a handy pocket guide color tabbed for quick access to important information. Easy to reference each drug is listed discussing the side effects, general impact on organ systems, potential toxicity, and risks before offering dosage recom 606 $aPregnant women$xDrug use 606 $aPregnant women$xMedical care 606 $aObstetrical pharmacology$vHandbooks, manuals, etc 606 $aFetus$xEffect of drugs on$vHandbooks, manuals, etc 606 $aNewborn infants$xEffect of drugs on$vHandbooks, manuals, etc 608 $aElectronic books. 615 0$aPregnant women$xDrug use. 615 0$aPregnant women$xMedical care. 615 0$aObstetrical pharmacology 615 0$aFetus$xEffect of drugs on 615 0$aNewborn infants$xEffect of drugs on 676 $a618.32 701 $aSchaefer$b Christof$0974950 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910458841103321 996 $aDrugs during pregnancy and lactation$92220013 997 $aUNINA LEADER 04082nam 22009013u 450 001 9910555235403321 005 20250705110026.0 010 $a9781478092117 010 $a1478092114 010 $a9780822394808 010 $a0822394804 010 $a9781283925051 010 $a1283925052 024 7 $a10.1515/9780822394808 035 $a(CKB)2550000000996523 035 $a(EBL)1173002 035 $a(OCoLC)832313848 035 $a(SSID)ssj0000803560 035 $a(PQKBManifestationID)11508829 035 $a(PQKBTitleCode)TC0000803560 035 $a(PQKBWorkID)10810568 035 $a(PQKB)11532051 035 $a(DE-B1597)554652 035 $a(DE-B1597)9780822394808 035 $a(OCoLC)1202624868 035 $a(DE-B1597)663293 035 $a(DE-B1597)9781478092117 035 $a(ScCtBLL)6ecde13a-87d5-4c4f-b389-e390b1929b56 035 $a(Perlego)1466835 035 $a(ODN)ODN0010711185 035 $a(oapen)doab78358 035 $a(EXLCZ)992550000000996523 100 $a20130527d2012|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aFood, Farms, and Solidarity $eFrench Farmers Challenge Industrial Agriculture and Genetically Modified Crops 210 $aDurham $cDuke University Press$d2012 210 1$a[s.l.] :$cDuke University Press,$d2013. 215 $a1 online resource (349 p.) 225 1 $aNew ecologies for the twenty-first century 300 $aDescription based upon print version of record. 311 08$a9780822351184 311 08$a0822351188 311 08$a9780822351276 311 08$a0822351277 327 $aContents; About the series; Acknowledgments; 1. Introduction: Creating a New Rationality of Agriculture in a Postindustrial World; Part I: Toward a New Rationality of Agriculture; 2. The New Paysan Movements: French Industrialized Agriculture and the Rise of the Postindustrial Paysan; 3. The Confe?de?ration Paysanne: Philosophy, Structure, and Constituency; Part II: The Confe?de?ration Paysanne's Early Anti-GMO Campaign, from Risk to Globalization; 4. Union Activism and Programs: Early Campaigns and Paysan Agriculture; 5. We Have Always Been Modern: Toward a Progressive Anti-GMO Campaign 327 $a6. The Trial of the GMOS: Deploying Discourses from Risk to GlobalizationPart III: How France Grew Its Own Alter-globalization Movement; 7. Caravans, GMOS, and McDo: The Campaign Continues; 8. Operation Roquefort, Part I: Traveling to Washington, D.C.; 9. Operation Roquefort, Part II: The Battle of Seattle; 10. Postindustrial Paysans in a Post-Seattle World: New Movements, New Possibilities; 11. Conclusion: French Lessons; What's to Be Learned?; Notes; Works Cited; Index 330 $aChaia Heller follows one of France's largest farmers' unions as it joins with peasants internationally to contest the hegemony of genetically modified foods, free trade, and industrial agriculture. 410 0$aNew ecologies for the twenty-first century 606 $aAgriculture and state$xHistory$xPolitical activity$y20th century$zFrance 606 $aFarmers$xPolitical aspects$zFrance 606 $aGenetically modified foods$zFrance 606 $aSustainable agriculture$zFrance 606 $aAnti-globalization movement$zFrance 606 $aBusiness & Economics$2HILCC 606 $aAgricultural Economics$2HILCC 607 $aFrance 615 0$aAgriculture and state$xHistory$xPolitical activity 615 0$aFarmers$xPolitical aspects 615 0$aGenetically modified foods 615 0$aSustainable agriculture 615 0$aAnti-globalization movement 615 7$aBusiness & Economics 615 7$aAgricultural Economics 676 $a338.1/844 676 $a338.1844 686 $aNAT011000$aSOC002010$2bisacsh 700 $aHeller$b Chaia$01219183 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910555235403321 996 $aFood, Farms, and Solidarity$92819298 997 $aUNINA